Increased TIM-3 expression has also been documented in head and neck squamous cell carcinoma (HNSCC), where it correlates with tumor size, recurrence rates, nodal involvement, and clinical staging, indicating a possible association with adverse prognostic features in HNSCC [44,45]. Here, HAVCR2 is linked to head and neck squamous cell carcinoma.